Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5693)
All Articles published online
|
Publishing Process of This Article
|
Jul 6, 2020 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen P, Yu M, Zhang JL, Chen WY, Zhu L, Song Y, Jiang CY, Zhang S. Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report. World J Clin Cases 2020; 8(13): 2876-2884 [PMID: 32742998 DOI: 10.12998/wjcc.v8.i13.2876] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i13/2876.htm |
| Number | Citing Articles |
| 1 |
Lei Wang, Yingyu Huang, Xin Sun. Sintilimab combined with anlotinib as first-line treatment for advanced sarcomatoid carcinoma of head and neck: a case report and literature review. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1362160
|
| 2 |
|
| 3 |
Chunsen Wang, Xiang Yuan, Jianxin Xue. Targeted therapy for rare lung cancers: Status, challenges, and prospects. Molecular Therapy 2023; 31(7): 1960 doi: 10.1016/j.ymthe.2023.05.007
|
| 4 |
Yue Zheng, Yang Fu, Qin Zhong, Rong Deng, Yu Zhang. The treatment of advanced pulmonary sarcomatoid carcinoma. Future Oncology 2022; 18(6): 727 doi: 10.2217/fon-2021-1071
|
| 5 |
Parneet K. Cheema, Shantanu O. Banerji, Normand Blais, Quincy S.-C. Chu, Patrice Desmeules, Rosalyn A. Juergens, Natasha B. Leighl, Brandon S. Sheffield, Paul F. Wheatley-Price, Barbara L. Melosky. Canadian Consensus Recommendations on the Management of MET-Altered NSCLC. Current Oncology 2021; 28(6): 4552 doi: 10.3390/curroncol28060386
|
| 6 |
Yu Wang, Lin Yang, Jianyang Wang, Lin Gui, Wei Li, Zhiqiang Liu, Xiangyu Ma, Yin Yang, Luhua Wang, Nan Bi. Case Report: First Case of Consolidation Immunotherapy After Definitive Chemoradiotherapy in Mediastinal Lymph Node Metastatic Sarcomatoid Carcinoma. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.788856
|